Personnel Information

写真a

YOSHIDA Soichiro


Job title

Associate Professor

Graduating School 【 display / non-display

  • Tokyo Medical and Dental University, Faculty of Medicine, 2001.04, Graduated

Graduate School 【 display / non-display

  • Tokyo Medical and Dental University, Graduate School, Division of Medical Sciences, Doctor's Course, 2010.03, Completed

Campus Career 【 display / non-display

  • 2012.06
    -
    2016.12
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Assistant Professor
  • 2017.01
    -
    2020.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Urology, Assistant Professor
  • 2020.04
    -
    2021.09
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Departments of Surgery, Urology, Junior Associate Professor
  • 2021.01
    -
    2021.12
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Urology, Junior Associate Professor
  • 2021.10
    -
    2022.03
    Tokyo Medical and Dental University, Tokyo Medical and Dental University, Division of Clinical Medicine, Department of General Surgery, Urology, Junior Associate Professor
  • 2022.04
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Urology, Associate Professor

▼display all

External Career 【 display / non-display

  • 2010.06
    -
    2012.05
    National Cancer Institute, National Institutes of Health, Bethesda, Urologic Oncology Branch, Visiting Fellow

Academic Society Affiliations 【 display / non-display

  • American urological association

  • European Urological Association

 

Published Papers & Misc 【 display / non-display

  1. Yuki Nakamura, Hiroshi Fukushima, Kasumi Yoshitomi, Takahiko Soma, Masaki Kobayashi, Bo Fan, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii. Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer. Int J Urol. 2022.12; ( PubMed, DOI )

  2. Chen W, Yokoyama M, Kobayashi M, Fan B, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Ai M, Fushimi K, Nonomura N, Fujii Y. Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study Int J Urol. 2022.12;

  3. Yamaguchi Y, Yokoyama M, Takemoto A, Nakamura Y, Fukuda S, Uehara S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma. IJU case reports. 2022.11; 5 (6): 480-483. ( PubMed, DOI )

  4. Yamamoto S, Fukushima H, Fukuda S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab. Asia Pac J Clin Oncol . 2022.08; 18 (4): 410-418.

  5. Arita Y, Yoshida S, Shigeta K, Kwee TC, Edo H, Okawara N, Hashimoto M, Ishii R, Ueda R, Mikami S, Fujiwara M, Waseda Y, Kikuchi E, Fujii YJinzaki M. Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology Eur Urol Oncol . 2022.08; ( DOI )

  6. Matsumoto S, Arita Y, Yoshida S, Fukushima H, Kimura K, Yamada I, Tanaka H, Yagi F, Yokoyama M, Matsuoka Y, Oya M, Tateishi U, Jinzaki M, Fujii Y. Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation Abdom Radiol (NY) . 2022.06; 47 (6): 2178-2186.

  7. Matsuoka Y, Uehara S, Toda K, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y. Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy Urol Oncol . 2022.04; 40 (4): 161.

  8. Yoshida S, Matsushima H, Fujii Y. Classification of oligometastatic prostate cancer with additional consideration for hormone sensitivity World J Urol . 2022.03; 40 (3): 871-873.

  9. Yoshida S, Fujii Y. Editorial Comment from Dr Yoshida and Dr Fujii to Role of Vesical Imaging-Reporting and Data System in predicting muscle-invasive bladder cancer: A diagnostic meta-analysis Int J Urol . 2022.03; 29 (3): 196.

  10. Yuki Arita, Soichiro Yoshida, Thomas C Kwee, Hiromi Edo, Ryohei Kufukihara, Keisuke Shigeta, Misa Nagasaka, Ryo Takeshita, Haruka Okamura, Ryo Ueda, Ryota Ishii, Shigeo Okuda, Yasuhisa Fujii. Clinical utility of the Bosniak classification version 2019: Diagnostic value of adding magnetic resonance imaging to computed tomography examination. Eur J Radiol. 2022.03; 148 110163. ( PubMed, DOI )

  11. Uchida Y, Yoshida S, Arita Y, Shimoda H, Kimura K, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Jinzaki M, Fujii Y. Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma Diagnostics (Basel) (IF: 5.25; Q2). 2022.03;

  12. Kimura K, Yoshida S, Tsuchiya J, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Tateishi U, Fujii Y. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer Eur Radiol . 2022.01; 32 (1): 671-679.

  13. Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response 2022.01; 14 (3): 567.

  14. Yuki Arita, Hirotaka Akita, Hirokazu Fujiwara, Masahiro Hashimoto, Keisuke Shigeta, Thomas C Kwee, Soichiro Yoshida, Takeo Kosaka, Shigeo Okuda, Mototsugu Oya, Masahiro Jinzaki. Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements. Eur J Radiol Open. 2022; 9 100403. ( PubMed, DOI )

  15. Tanaka H*, Fukuda S, Kimura K, Fukawa Y, Yamamoto K, Fukushima H, Moriyama S, Yasuda Y, Uehara S, Waseda Y, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Tateishi U, Campbell SC, Fujii Y. . Defining tumour shape irregularity for preoperative risk stratification of clinically localised renal cell carcinoma Eur Urol Open Sci. . 2022;

  16. Fujiwara M, Yokoyama M, Toide M, Fujiwara R, Tanaka H, Oguchi T, Komai Y, Yoshida S, Matsuoka Y, Numao N, Yamamoto S, Fukui I, Yonese J, Fujii Y. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study Jpn J Clin Oncol. 2022;

  17. Ishikawa Y, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Sakai Y, Otsuka Y, Takazawa R, Yano M, Tsukamoto T, Okuno T, Noro A, Nagahama K, Kamata S, Fujii Y. Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study Diagnostics (Basel). 2021.12;

  18. Yuki Arita, Soichiro Yoshida, Thomas C Kwee, Hirotaka Akita, Shigeo Okuda, Yuki Iwaita, Kiyoko Mukai, Shunya Matsumoto, Ryo Ueda, Ryota Ishii, Ryuichi Mizuno, Yasuhisa Fujii, Mototsugu Oya, Masahiro Jinzaki. Diagnostic value of texture analysis of apparent diffusion coefficient maps for differentiating fat-poor angiomyolipoma from non-clear-cell renal cell carcinoma. Eur J Radiol. 2021.10; 143 109895. ( PubMed, DOI )

  19. Yamamoto S, Yoshida S, Ishii C, Takahara T, Arita Y, Fukushima H, Tanaka H, Yokoyama M, Matsuoka Y, Fujii Y. Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer. Journal of magnetic resonance imaging : JMRI. 2021.08; 54 (2): 401-408. ( PubMed, DOI )

  20. Chiara Lonati, Philipp Baumeister, Luca Afferi, Andrea Mari, Andrea Minervini, Wojciech Krajewski, Sosan Azizi, Kees Hendricksen, Alberto Martini, Andrea Necchi, Francesco Montorsi, Alberto Briganti, Renzo Colombo, Alessandro Tafuri, Alessandro Antonelli, Maria Angela Cerruto, Morgan Rouprêt, Alexandra Masson-Lecomte, Ekaterina Laukhtina, David D'Andrea, Shahrokh F Shariat, Francesco Soria, Giancarlo Marra, Paolo Gontero, Roberto Contieri, Rodolfo Hurle, Anne Sophie Valiquette, M Carmen Mir, Stefania Zamboni, Claudio Simeone, Tobias Klatte, Jeremy Yuen-Chun Teoh, Soichiro Yoshida, Yasuhisa Fujii, Roberto Carando, Gerald B Schulz, Livio Mordasini, Agostino Mattei, Marco Moschini, . Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration. Eur Urol Focus. 2021.08; ( PubMed, DOI )

  21. Yoshida S, Fujii Y. Editorial Comment to Long-term clinical outcomes of external beam radiation therapy for oligometastatic prostate cancer: A combination of prostate-targeted treatment and metastasis-directed therapy. International journal of urology : official journal of the Japanese Urological Association. 2021.07; 28 (7): 756. ( PubMed, DOI )

  22. Saito K, Matsuoka Y, Toda K, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y. Medium-term oncological and functional outcomes of hemi-gland brachytherapy using iodine-125 seeds for intermediate-risk unilateral prostate cancer. Brachytherapy. 2021.07; 20 (4): 842-848. ( PubMed, DOI )

  23. Maruyama R, Fukushima H, Fukuda S, Yasuda Y, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y. Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patients. International journal of urology : official journal of the Japanese Urological Association. 2021.07; ( PubMed, DOI )

  24. Yoshida S, Matsuoka Y, Toda K, Uehara S, Tanaka H, Yokoyama M, Saito K, Yoshimura R, Fujii Y. Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy. IJU case reports. 2021.07; 4 (4): 228-230. ( PubMed, DOI )

  25. Yoshida S, Takahara T, Arita Y, Toda K, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Genuine- and induced-oligometastatic castration-resistant prostate cancer: clinical features and clinical outcomes after progressive site-directed therapy. International urology and nephrology. 2021.06; 53 (6): 1119-1125. ( PubMed, DOI )

  26. Kimura K, Yoshida S, Tsuchiya J, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Tateishi U, Fujii Y. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer. European radiology. 2021.06; ( PubMed, DOI )

  27. Yamazaki A, Ito T, Sugimoto M, Yoshida S, Honda K, Kawashima Y, Fujikawa T, Fujii Y, Tsutsumi T. Patient-specific virtual and mixed reality for immersive, experiential anatomy education and for surgical planning in temporal bone surgery. Auris, nasus, larynx. 2021.05; ( PubMed, DOI )

  28. Yoshida S, Takahara T, Arita Y, Sakaino S, Katahira K, Fujii Y. Whole-body diffusion-weighted magnetic resonance imaging: Diagnosis and follow up of prostate cancer and beyond. International journal of urology : official journal of the Japanese Urological Association. 2021.05; 28 (5): 502-513. ( PubMed, DOI )

  29. Arita Y, Yoshida S, Waseda Y, Takahara T, Ishii C, Ueda R, Kwee TC, Miyahira K, Ishii R, Okuda S, Jinzaki M, Fujii Y. Diagnostic value of computed high b-value whole-body diffusion-weighted imaging for primary prostate cancer. European journal of radiology. 2021.04; 137 109581. ( PubMed, DOI )

  30. Yoshida S, Fujii Y. Editorial Comment to Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer. IJU case reports. 2021.03; 4 (2): 73-74. ( PubMed, DOI )

  31. Yasuda Yosuke, Saito Kazutaka, Tanaka Hajime, Uehara Sho, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique(和訳中) International Journal of Urology. 2021.03; 28 (3): 302-307. ( ichushi )

  32. Yoshida Soichiro, Fujii Yasuhisa. Editorial Comment to Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer(和訳中) IJU Case Reports. 2021.03; 4 (2): 73-74. ( ichushi )

  33. Yoshida Soichiro, Takahara Taro, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa. Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer?(和訳中) International Journal of Urology. 2021.02; 28 (2): 241-242. ( ichushi )

  34. Fukuda S, Saito K, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kageyama Y, Fujii Y. Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab. Journal for immunotherapy of cancer. 2021.02; 9 (2): ( PubMed, DOI )

  35. Yoshida S, Matsushima H, Fujii Y. Classification of oligometastatic prostate cancer with additional consideration for hormone sensitivity. World journal of urology. 2021.01; ( PubMed, DOI )

  36. Fukushima H, Yoshida S, Kijima T, Nakamura Y, Fukuda S, Uehara S, Yasuda Y, Tanaka H, Yokoyama M, Matsuoka Y, Fujii Y. Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti-PD-1 Treatment Efficacy in Urothelial Carcinoma. International journal of molecular sciences. 2021.01; 22 (2): ( PubMed, DOI )

  37. Soma T, Yokoyama M, Uchida Y, Kirimura S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report. International cancer conference journal. 2021.01; 10 (1): 20-23. ( PubMed, DOI )

  38. Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems(和訳中) International Journal of Urology. 2021.01; 28 (1): 127-129. ( ichushi )

  39. Waseda Y, Yoshida S, Arita Y, Takahara T, Sakamoto T, Saito K, Fujii Y. Potential of Perfusion Magnetic Resonance Imaging to Predict Residual Renal Function after Radical Nephroureterectomy. Urologia internationalis. 2021; 105 (5-6): 507-513. ( PubMed, DOI )

  40. Yasuda Y, Saito K, Tanaka H, Uehara S, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Kihara K, Fujii Y. Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique. International journal of urology : official journal of the Japanese Urological Association. 2020.12; ( PubMed, DOI )

  41. Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Longitudinal changes in patient-reported outcomes after artificial urinary sphincter implantation Low Urin Tract Symptoms. 2020.12;

  42. Yoshida S, Takahara T, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer? International journal of urology : official journal of the Japanese Urological Association. 2020.11; ( PubMed, DOI )

  43. Fukushima H, Kijima T, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Matsubara N, Numao N, Sakai Y, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study. Cancer medicine. 2020.11; 9 (22): 8355-8363. ( PubMed, DOI )

  44. Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Saito Kazutaka, Fujii Yasuhisa. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images(和訳中) International Journal of Urology. 2020.09; 27 (9): 760-766. ( ichushi )

  45. Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report. Anti-cancer drugs. 2020.09; 31 (8): 866-871. ( PubMed, DOI )

  46. Kijima T, Yamamoto H, Saito K, Kusuhara S, Yoshida S, Yokoyama M, Matsuoka Y, Numao N, Sakai Y, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab. Cancer immunology, immunotherapy : CII. 2020.09; ( PubMed, DOI )

  47. Kijima T, Yamamoto H, Saito K, Kusuhara S, Yoshida S, Yokoyama M, Matsuoka Y, Numao N, Sakai Y, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab Cancer Immunol Immunother. 2020.09;

  48. Yoshida S, Takahara T, Arita Y, Toda K, Yoshimura R, Fujii Y. Patterns of failure after progressive site-directed therapy in oligo-progressive castration-resistant prostate cancer. International journal of urology : official journal of the Japanese Urological Association. 2020.07; 27 (7): 634-635. ( PubMed, DOI )

  49. Kaneko K, Yoshida S, Yamamoto K, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted magnetic resonance imaging. International journal of urology : official journal of the Japanese Urological Association. 2020.07; 27 (7): 599-604. ( PubMed, DOI )

  50. Kaneko Kasumi, Yoshida Soichiro, Yamamoto Kouhei, Arita Yuki, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted magnetic resonance imaging(和訳中) International Journal of Urology. 2020.07; 27 (7): 599-604. ( ichushi )

  51. Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Yoshimura Ryoichi, Fujii Yasuhisa. Patterns of failure after progressive site-directed therapy in oligo-progressive castration-resistant prostate cancer(和訳中) International Journal of Urology. 2020.07; 27 (7): 634-635. ( ichushi )

  52. Kijima T, Fukushima H, Kusuhara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Sakai Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review. Clinical genitourinary cancer. 2020.07; ( PubMed, DOI )

  53. Yoshida Soichiro, Sugimoto Maki, Fukuda Shohei, Taniguchi Naoji, Saito Kazutaka, Fujii Yasuhisa. Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy (vol 27, pg 471, 2020) INTERNATIONAL JOURNAL OF UROLOGY. 2020.07; 27 (7): 636. ( DOI )

  54. Kijima T, Fukushima H, Kusuhara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Sakai Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review Clin Genitourin Cancer. 2020.07;

  55. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images. International journal of urology : official journal of the Japanese Urological Association. 2020.06; ( PubMed, DOI )

  56. Nakamura Yuki, Yokoyama Minato, Yoshida Soichiro, Tanaka Hajime, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Minami Isao, Yoshimoto Takanobu, Naito Shotaro, Ogawa Yoshihiro, Yamada Tetsuya, Uchida Shinichi, Fujii Yasuhisa. クッシング症候群患者における副腎摘除後の術後腎機能障害と長期にわたる腎機能変化(Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome) International Journal of Urology. 2020.05; 27 (5): 395-400. ( ichushi )

  57. Yoshida Soichiro, Taniguchi Naoji, Moriyama Shingo, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. MRI撮影-超音波検査融合画像による前立腺生検の患者説明におけるバーチャルリアリティの応用(Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy) International Journal of Urology. 2020.05; 27 (5): 471-472. ( ichushi )

  58. Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Longitudinal changes in patient-reported outcomes after artificial urinary sphincter implantation. Lower urinary tract symptoms. 2020.04; ( PubMed, DOI )

  59. Yoshida S, Taniguchi N, Moriyama S, Matsuoka Y, Saito K, Fujii Y. Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy. International journal of urology : official journal of the Japanese Urological Association. 2020.03; ( PubMed, DOI )

  60. Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome. International journal of urology : official journal of the Japanese Urological Association. 2020.03; ( PubMed, DOI )

  61. Tanaka H, Fukushima H, Kijima T, Nakamura Y, Yajima S, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer. International journal of urology : official journal of the Japanese Urological Association. 2020.03; 27 (3): 236-243. ( PubMed, DOI )

  62. Tanaka Hajime, Fukushima Hiroshi, Kijima Toshiki, Nakamura Yuki, Yajima Shugo, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. 筋層浸潤性膀胱癌の高齢患者への選択的4者併用膀胱温存療法の実行可能性と成績(Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer) International Journal of Urology. 2020.03; 27 (3): 236-243. ( ichushi )

  63. Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome Int J Urol. 2020 Mar 11. doi: 10.1111/iju.14205. 2020.03;

  64. Fukushima H, Inoue M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Incidence and Risk Factors of Hypertension Following Partial Nephrectomy in Patients With Renal Tumors: A Cross-sectional Study of Postoperative Home Blood Pressure and Antihypertensive Medications. Clinical genitourinary cancer. 2020.02; ( PubMed, DOI )

  65. Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer. European urology focus. 2020.01; ( PubMed, DOI )

  66. Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer Eur Urol Focus. 2020;

  67. Fukushima H, Inoue M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Incidence and risk factors of hypertension following partial nephrectomy in patients with renal tumors: a cross-sectional study of postoperative home blood pressure and antihypertensive medications Clin Genitourin Cancer. 2020;

  68. Fukushima H, Kijima T, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Matsubara N, Numao N, Sakai Y, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: a preliminary study Cancer Med. 2020; 9: 8355-8363. doi: 10.1002/cam4.3445. 2020;

  69. Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report Anticancer Drugs. 2020; 31: 866-871. doi: 10.1097/CAD.0000000000000982.. 2020;

  70. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Yokoyama M, Fujii Y. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy Int J Urol. 2020 Oct 27. doi: 10.1111/iju.14410. 2020;

  71. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores Spatial analysis using magnetic resonance-ultrasound fusion images. Int J Urol. 2020; 27: 760-766. 2020;

  72. Tanaka H, Fukushima H, Kijima T, Nakamura Y, Yajima S, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer Int J Urol. 2020; 27: 236-243. *Equal contribution. 2020;

  73. Kaneko K, Yoshida S, Yamamoto K, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. . Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted magnetic resonance imaging. Int J Urol. 2020 Jul;27(7):599-604. doi: 10.1111/iju.14251.. 2020;

  74. Yoshida S, Taniguchi N, Moriyama S, Matsuoka Y, Saito K, Fujii Y. . Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy. Int J Urol. 2020; 27: 471-472. doi: 10.1111/iju.14204.. 2020;

  75. Yoshida S, Takahara T, Arita Y, Toda K, Yoshimura R, Fujii Y. . Patterns of failure after progressive site-directed therapy in oligo-progressive castration-resistant prostate cancer. Int J Urol. 2020; 27: 634-635. doi: 10.1111/iju.14249.. 2020;

  76. SoichiroYoshida1TaroTakahara23ChikakoIshii3YukiArita34YumaWaseda1ToshikiKijima1MinatoYokoyama1JunichiroIshioka1YohMatsuoka1KazutakaSaito1YasuhisaFujii. METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer 2019.12;

  77. Kijima T, Tanaka H, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy. Clinical genitourinary cancer. 2019.12; ( PubMed, DOI )

  78. Yoshida S, Takahara T, Ishii C, Arita Y, Waseda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer. Clinical genitourinary cancer. 2019.12; ( PubMed, DOI )

  79. Kobayashi Masaki, Tanaka Hajime, Tateishi Ukihide, Numao Noboru, Yonese Junji, Ito Masaya, Koga Fumitaka, Fukushima Hiroshi, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma. Int J Urol. 2019.08; 26 (8): 820-826. ( PubMed, DOI )

  80. Kijima Toshiki, Tanaka Hajime, Koga Fumitaka, Masuda Hitoshi, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients. BJU Int. 2019.08; 124 (2): 242-250. ( PubMed, DOI )

  81. Kobayashi Masaki, Tanaka Hajime, Tateishi Ukihide, Numao Noboru, Yonese Junji, Ito Masaya, Koga Fumitaka, Fukushima Hiroshi, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma International Journal of Urology. 2019.08; 26 (8): 820-826. ( ichushi )

  82. Yajima Shugo, Yoshida Soichiro, Takahara Taro, Arita Yuki, Tanaka Hiroshi, Waseda Yuma, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progression. Eur Radiol. 2019.07; 29 (7): 3881-3888. ( PubMed, DOI )

  83. Yoshida Soichiro, Fujii Yasuhisa. Editorial Comment to Virtual reality of three-dimensional surgical field for surgical planning and intraoperative management. Int J Urol. 2019.07; ( PubMed, DOI )

  84. Yoshida Soichiro, Maeda Takeshi, Yokoyama Minato, Toide Masahiro, Saito Kazutaka, Fujii Yasuhisa. Application of eye tracking as a user interface for urological surgery. Int J Urol. 2019.06; 26 (6): 680-681. ( PubMed, DOI )

  85. Yoshida Soichiro, Sugimoto Maki, Fukuda Shohei, Taniguchi Naoji, Saito Kazutaka, Fujii Yasuhisa. Mixed reality computed tomography-based surgical planning for partial nephrectomy using a head-mounted holographic computer. Int J Urol. 2019.06; 26 (6): 681-682. ( PubMed, DOI )

  86. Yoshida Soichiro, Takahara Taro, Arita Yuki, Ishii Chikako, Uchida Yusuke, Nakagawa Keiko, Toda Kazuma, Sakamoto Tsuyoshi, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Yoshimura Ryoichi, Fujii Yasuhisa. Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor. Int J Radiat Oncol Biol Phys. 2019.06; ( PubMed, DOI )

  87. Arita Yuki, Takahara Taro, Yoshida Soichiro, Kwee Thomas C, Yajima Shugo, Ishii Chikako, Ishii Ryota, Okuda Shigeo, Jinzaki Masahiro, Fujii Yasuhisa. Quantitative Assessment of Bone Metastasis in Prostate Cancer Using Synthetic Magnetic Resonance Imaging. Invest Radiol. 2019.05; ( PubMed, DOI )

  88. Kijima Toshiki, Fukuda Shohei, Fukushima Hiroshi, Moriyama Shingo, Uehara Sho, Yasuda Yosuke, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. Clinical outcomes of muscle-invasive bladder cancer patients with hydronephrosis treated with tetra-modality bladder sparing therapy incorporating consolidative partial cystectomy. JOURNAL OF CLINICAL ONCOLOGY. 2019.03; 37 (7):

  89. Araki Saori, Kijima Toshiki, Waseda Yuma, Komai Yoshinobu, Nakanishi Yasukazu, Uehara Sho, Yasuda Yosuke, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Nakano Yujiro, Yoshimoto Takanobu, Uchida Tokujiro, Fujii Yasuhisa. Incidence and predictive factors of hypoglycemia after pheochromocytoma resection. Int J Urol. 2019.02; 26 (2): 273-277. ( PubMed, DOI )

  90. Araki Saori, Kijima Toshiki, Waseda Yuma, Komai Yoshinobu, Nakanishi Yasukazu, Uehara Sho, Yasuda Yosuke, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Nakano Yujiro, Yoshimoto Takanobu, Uchida Tokujiro, Fujii Yasuhisa. 褐色細胞腫切除後の低血糖の発生率と予測因子(Incidence and predictive factors of hypoglycemia after pheochromocytoma resection) International Journal of Urology. 2019.02; 26 (2): 273-277. ( ichushi )

  91. Kawamura Naoko, Yokoyama Minato, Tanaka Hajime, Nakayama Takayuki, Yasuda Yosuke, Kijima Toshiki, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 無阻血腎部分切除術後の急性腎障害と中期腎機能(Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy) International Journal of Urology. 2019.01; 26 (1): 113-118. ( ichushi )

  92. Yoshida Soichiro, Fujii Yasuhisa. High cell proliferation as a predictive factor for favorable response to chemoradiotherapy against bladder cancer CANCER SCIENCE. 2018.12; 109 1220.

  93. Nakayama T, Saito K, Kumagai J, Nakajima Y, Kijima T, Yoshida S, Kihara K, Fujii Y. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma. Clinical genitourinary cancer. 2018.12; 16 (6): e1151-e1158. ( PubMed, DOI )

  94. Kawamura N, Saito K, Inoue M, Ito M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kihara K, Fujii Y. Adherent Perinephric Fat in Asian Patients: Predictors and Impact on Perioperative Outcomes of Partial Nephrectomy. Urologia internationalis. 2018.10; 1-6. ( PubMed, DOI )

  95. Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 234.

  96. Saito Kazutaka, Matsuoka Yoh, Yoshida Soichiro, Fujii Yasuhisa. MRI/ultrasound elastic fusion prostate biopsy : application to lesion - specific treatment of local therapy INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 167.

  97. Yoshida Soichiro, Takahara Taro, Ishii Chikako, Nakagawa Keiko, Toda Kazuma, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Yoshimura Ryoichi, Kihara Kazunori, Fujii Yasuhisa. Loco-regional radiotherapy targeting for oligo-progressive CRPC on the diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 358.

  98. Yasuda Yosuke, Saito Kazutaka, Soma Takahiko, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy: Perioperative outcomes INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 230.

  99. Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 234.

  100. Kawamura N, Yokoyama M, Tanaka H, Nakayama T, Yasuda Y, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy. International journal of urology : official journal of the Japanese Urological Association. 2018.09; ( PubMed, DOI )

  101. Hajime Tanaka, Soichiro Yoshida, Fumitaka Koga, Kazuma Toda, Ryoichi Yoshimura, Yutaka Nakajima, Emiko Sugawara, Takumi Akashi, Yuma Waseda, Masaharu Inoue, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiotherapy. International Journal of Radiation Oncology, Biology, Physics. 2018.06; ( PubMed, DOI )

  102. Moriyama Shingo, Yoshida Soichiro, Tanaka Hajime, Tanaka Hiroshi, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. T2強調MRIにおける小径腎腫瘍の信号強度比曲線解析 脂肪成分の少ない腎血管筋脂肪腫と腎細胞癌との鑑別(Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma) International Journal of Urology. 2018.06; 25 (6): 554-560. ( ichushi )

  103. Junichiro Ishioka, Yoh Matsuoka, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Kazutaka Saito, Kazunori Kihara, Noboru Numao, Tomo Kimura, Kosei Kudo, Itsuo Kumazawa, Yasuhisa Fujii. Computer-aided diagnosis of prostate cancer on magnetic resonance imaging using a convolutional neural network algorithm. BJU Int.. 2018.05; ( PubMed, DOI )

  104. Shingo Moriyama, Soichiro Yoshida, Hajime Tanaka, Hiroshi Tanaka, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma. international journal of urology. 2018.03; ( PubMed, DOI )

  105. Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Clinical outcomes of patients with histologic variants of urothelial carcinoma treated with tetra-modality bladder-sparing protocol incorporating consolidative partial cystectomy. JOURNAL OF CLINICAL ONCOLOGY. 2018.02; 36 (6):

  106. Sho Uehara, Soichiro Yoshida, Hiroshi Tanaka, Yosuke Yasuda, Hajime Tanaka, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Prediction of Intraoperative Urinary Collecting System Entry in Patients with Peripheral Renal Tumors Undergoing Partial Nephrectomy: Usefulness of Tumor-Centered Multiplanar Reconstruction. urologia internationalis. 2018.01; 100 (1): 85-91. ( PubMed, DOI )

  107. Yuma Waseda, Soichiro Yoshida, Taro Takahara, Thomas Christian Kwee, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer. Journal of magnetic resonance imaging : JMRI. 2017.08; 46 (2): 490-496. ( PubMed, DOI )

  108. Soichiro Yoshida, Tsuneo Fukuyo, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Real-time three-dimensional image angle rectification to improve hand-eye coordination in single-port laparoendoscopic surgery. International journal of urology : official journal of the Japanese Urological Association. 2017.08; 24 (8): 639-640. ( PubMed, DOI )

  109. Yoh Matsuoka, Junichiro Ishioka, Hiroshi Tanaka, Tomo Kimura, Soichiro Yoshida, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Impact of the Prostate Imaging Reporting and Data System, Version 2, on MRI Diagnosis for Extracapsular Extension of Prostate Cancer. AJR. American journal of roentgenology. 2017.08; 209 (2): W76-W84. ( PubMed, DOI )

  110. Yoshida Soichiro, Fukuyo Tsuneo, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 単孔式腹腔鏡下手術における手-目協調の改善のためのリアルタイム三次元画像の角度調整(Real-time three-dimensional image angle rectification to improve hand-eye coordination in single-port laparoendoscopic surgery) International Journal of Urology. 2017.08; 24 (8): 639-640. ( ichushi )

  111. Toshinori Nishizawa, Soichiro Yoshida, Fumitaka Koga, Hiroshi Tanaka, Mihiro Kaga, Kotaro Watanabe, Hiroshi Fukushima, Yasukazu Nakanishi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Standardization of the apparent diffusion coefficient value of bladder cancer across different centers: Applicability in predicting aggressive pathologic phenotypes. Clinical imaging. 2017.07; 44 121-126. ( PubMed, DOI )

  112. Soichiro Yoshida, Taro Takahara, Thomas C Kwee, Yuma Waseda, Shuichiro Kobayashi, Yasuhisa Fujii. DWI as an Imaging Biomarker for Bladder Cancer. AJR. American journal of roentgenology. 2017.06; 208 (6): 1218-1228. ( PubMed, DOI )

  113. Yuki Nakamura, Soichiro Yoshida, Hiroshi Tanaka, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection. Urologia internationalis. 2017.03; 98 (3): 298-303. ( PubMed, DOI )

  114. Takayuki Nakayama, Noboru Numao, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. A novel interactive educational system in the operating room--the IE system. BMC medical education. 2016.02; 16 44. ( PubMed, DOI )

  115. Hajime Tanaka, Soichiro Yoshida, Yoshinobu Komai, Yasuyuki Sakai, Shinji Urakami, Takeshi Yuasa, Shinya Yamamoto, Hitoshi Masuda, Mitsuru Koizumi, Atsushi Kohno, Iwao Fukui, Junji Yonese, Yasuhisa Fujii, Kazunori Kihara. Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management. Urologia internationalis. 2016.01; 96 (1): 65-72. ( PubMed, DOI )

  116. Kenji Tanabe, Soichiro Yoshida, Fumitaka Koga, Masaharu Inoue, Shuichiro Kobayashi, Junichiro Ishioka, Tomoki Tamura, Emiko Sugawara, Kazutaka Saito, Takumi Akashi, Yasuhisa Fujii, Kazunori Kihara. High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol. Clinical genitourinary cancer. 2015.08; 13 (4): e243-e251. ( PubMed, DOI )

  117. Soichiro Yoshida, Asami Sasaki, Chikage Sato, Mutsuko Yamazaki, Junya Takayasu, Naofumi Tanaka, Norie Okabayashi, Hiromi Hirano, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. A Novel Approach to Surgical Instructions for Scrub Nurses by Using See-Through-Type Head-Mounted Display. Comput Inform Nurs. 2015.08; 33 (8): 335-338. ( PubMed, DOI )

  118. Soichiro Yoshida, Kazunori Kihara, Tsuneo Fukuyo, Junichiro Ishioka, Kazutaka Saito, Yasuhisa Fujii. Novel three-dimensional image system for transurethral surgery. Int. J. Urol.. 2015.07; 22 (7): 714-715. ( PubMed, DOI )

  119. Soichiro Yoshida, Naotaka Fukui, Kazutaka Saito, Yasuhisa Fujii, Yukio Kageyama, Kazunori Kihara. Novel image monitoring system using a head-mounted display for assistants in da Vinci surgery. Int. J. Urol.. 2015.05; 22 (5): 520-521. ( PubMed, DOI )

  120. Junichiro Ishioka, Kazutaka Saito, Toshiki Kijima, Yasukazu Nakanishi, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Noboru Numao, Fumitaka Koga, Hitoshi Masuda, Yasuhisa Fujii, Yasuyuki Sakai, Chizuru Arisawa, Tetsuo Okuno, Katsuhi Nagahama, Shigeyoshi Kamata, Mizuaki Sakura, Junji Yonese, Shinji Morimoto, Akira Noro, Toshihiko Tsujii, Satoshi Kitahara, Shuichi Gotoh, Yotsuo Higashi, Kazunori Kihara. Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy. BJU international. 2015.05; 115 (5): 705-712. ( PubMed, DOI )

  121. Soichiro Yoshida, Masaya Ito, Manabu Tatokoro, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Multitask Imaging Monitor for Surgical Navigation: Combination of Touchless Interface and Head-Mounted Display. Urologia internationalis. 2015.04; ( PubMed, DOI )

  122. Masaya Ito, Kazunori Kihara, Soichiro Yoshida, Manabu Tatokoro, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii. Patient's Self-monitoring of Transurethral Surgical Images Using a Head-mounted Display Urology Case Reports. 2015.03; 3 (2): 27-29. ( DOI )

  123. Hideki Takeshita, Satoru Kawakami, Noboru Numao, Mizuaki Sakura, Manabu Tatokoro, Shinya Yamamoto, Toshiki Kijima, Yoshinobu Komai, Kazutaka Saito, Fumitaka Koga, Yasuhisa Fujii, Iwao Fukui, Kazunori Kihara. Diagnostic performance and safety of a three-dimensional 14-core systematic biopsy method. BJU international. 2015.03; 115 (3): 412-418. ( PubMed, DOI )

  124. Soichiro Yoshida, Kazunori Kihara, Hideki Takeshita, Yasukazu Nakanishi, Toshiki Kijima, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii. Head-mounted display for a personal integrated image monitoring system: ureteral stent placement. Urologia internationalis. 2015.01; 94 (1): 117-120. ( PubMed, DOI )

  125. Masaharu Inoue, Kazunori Kihara, Soichiro Yoshida, Masaya Ito, Hideki Takeshita, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii. A novel approach to patient self-monitoring of sonographic examinations using a head-mounted display. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine. 2015.01; 34 (1): 29-35. ( PubMed, DOI )

  126. Manabu Tatokoro, Fumitaka Koga, Soichiro Yoshida, Kazunori Kihara. Heat shock protein 90 targeting therapy: state of the art and future perspective. EXCLI journal. 2015; 14 48-58. ( PubMed, DOI )

  127. Yoshida Soichiro, Koga Fumitaka, Masuda Hitoshi, Fujii Yasuhisa, Kihara Kazunori. Role of diffusion-weighted magnetic resonance imaging as an imaging biomarker of urothelial carcinoma. International journal of urology : official journal of the Japanese Urological Association. 2014.12; 21 (12): 1190-1200. ( PubMed, DOI )

  128. Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Fujii Yasuhisa. A head-mounted display-based personal integrated-image monitoring system for transurethral resection of the prostate. Wideochir Inne Tech Malo Inwazyjne. 2014.12; 9 (4): 644-649. ( PubMed, DOI )

  129. Fujii Yasuhisa, Kihara Kazunori, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka. A three-dimensional head-mounted display system (RoboSurgeon system) for gasless laparoendoscopic single-port partial cystectomy. Wideochir Inne Tech Malo Inwazyjne. 2014.12; 9 (4): 638-643. ( PubMed, DOI )

  130. Ishioka Junichiro, Kihara Kazunori, Higuchi Saori, Nakayama Takayuki, Takeshita Hideki, Yoshida Soichiro, Nakanishi Yasukazu, Kijima Toshiki, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa. New head-mounted display system applied to endoscopic management of upper urinary tract carcinomas. Int Braz J Urol. 2014.11; 40 (6): 842-845. ( PubMed )

  131. Inoue Masaharu, Koga Fumitaka, Yoshida Soichiro, Tamura Tomoki, Fujii Yasuhisa, Ito Eisaku, Kihara Kazunori. Significance of ERBB2 overexpression in therapeutic resistance and cancer-specific survival in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. International journal of radiation oncology, biology, physics. 2014.10; 90 (2): 303-311. ( PubMed, DOI )

  132. Ishioka Junichiro, Masuda Hitoshi, Kijima Toshiki, Tatokoro Manabu, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Fujii Yasuhisa, Sakai Yasuyuki, Arisawa Chizuru, Okuno Tetsuo, Nagahama Katsuhi, Kamata Shigeyoshi, Yonese Junji, Kageyama Yukio, Noro Akira, Morimoto Shinji, Tsujii Toshihiko, Kitahara Satoshi, Gotoh Shuichi, Kihara Kazunori. Bimodal pattern of the impact of body mass index on cancer-specific survival of upper urinary tract urothelial carcinoma patients. Anticancer research. 2014.10; 34 (10): 5683-5688. ( PubMed )

  133. Uchida Yusuke, Yoshida Soichiro, Kobayashi S, Koga F, Ishioka J, Satoh S, Ishii C, Tanaka H, Matsuoka Y, Numao N, Saito K, Masuda H, Fujii Y, Kihara K. Diffusion-weighted MRI as a potential imaging biomarker reflecting the metastatic potential of upper urinary tract cancer. The British journal of radiology. 2014.10; 87 (1042): 20130791. ( PubMed, DOI )

  134. Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Fujii Yasuhisa. Instructive head-mounted display system: pointing device using a vision-based finger tracking technique applied to surgical education. Wideochir Inne Tech Malo Inwazyjne. 2014.09; 9 (3): 449-452. ( PubMed, DOI )

  135. Nakayama Takayuki, Saito Kazutaka, Fujii Yasuhisa, Abe-Suzuki Shiho, Nakanishi Yasukazu, Kijima Toshiki, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Kihara Kazunori. Pre-operative risk stratification for cancer-specific survival in patients with renal cell carcinoma with venous involvement who underwent nephrectomy. Japanese journal of clinical oncology. 2014.08; 44 (8): 756-761. ( PubMed, DOI )

  136. Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Tanaka Hiroshi, Kumagai Jiro, Yoshida Soichiro, Ishioka Junichiro, Koga Fumitaka, Masuda Hitoshi, Kawakami Satoru, Fujii Yasuhisa, Kihara Kazunori. Candidate selection for quadrant-based focal ablation through a combination of diffusion-weighted magnetic resonance imaging and prostate biopsy. BJU international. 2014.08; ( PubMed, DOI )

  137. Takeshita Hideki, Kihara Kazunori, Yoshida Soichiro, Higuchi Saori, Ito Masaya, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa. Clinical application of a modern high-definition head-mounted display in sonography. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine. 2014.08; 33 (8): 1499-1504. ( PubMed, DOI )

  138. Yoshida Soichiro, Koga Fumitaka, Kobayashi Shuichiro, Tanaka Hiroshi, Satoh Shiro, Fujii Yasuhisa, Kihara Kazunori. Diffusion-weighted magnetic resonance imaging in management of bladder cancer, particularly with multimodal bladder-sparing strategy. World journal of radiology. 2014.06; 6 (6): 344-354. ( PubMed, DOI )

  139. Bae Hyeyeol, Yoshida Soichiro, Matsuoka Yoh, Nakajima Hiroshi, Ito Eisaku, Tanaka Hiroshi, Oya Miyako, Nakayama Takayuki, Takeshita Hideki, Kijima Toshiki, Ishioka Junichiro, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Akashi Takumi, Fujii Yasuhisa, Kihara Kazunori. Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer. International urology and nephrology. 2014.03; 46 (3): 555-561. ( PubMed, DOI )

  140. Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Tanaka Hiroshi, Kumagai Jiro, Yoshida Soichiro, Koga Fumitaka, Masuda Hitoshi, Kawakami Satoru, Fujii Yasuhisa, Kihara Kazunori. Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy. European urology. 2014.01; 65 (1): 186-192. ( PubMed, DOI )

  141. Kobayashi Shuichiro, Koga Fumitaka, Kajino Kohei, Yoshida Soichiro, Ishii Chikako, Tanaka Hiroshi, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Yamada Tetsuo, Kihara Kazunori. Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer. Journal of magnetic resonance imaging : JMRI. 2014.01; 39 (1): 172-178. ( PubMed, DOI )

  142. Mollapour Mehdi, Bourboulia Dimitra, Beebe Kristin, Woodford Mark R, Polier Sigrun, Hoang Anthony, Chelluri Raju, Li Yu, Guo Ailan, Lee Min-Jung, Fotooh-Abadi Elham, Khan Sahar, Prince Thomas, Miyajima Naoto, Yoshida Soichiro, Tsutsumi Shinji, Xu Wanping, Panaretou Barry, Stetler-Stevenson William G, Bratslavsky Gennady, Trepel Jane B, Prodromou Chrisostomos, Neckers Len. Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors. Molecular Cell. 2014.01; 53 (2): 317-329. ( PubMed, DOI )

  143. Yachida Yuki, Yoshida Soichiro, Takeshita Hideki, Sawamura Chigusa, Tanaka Hiroshi, Satoh Shiro, Uchida Yusuke, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Fujii Yasuhisa, Kihara Kazunori. Bone abnormal signal incidentally found in pre-biopsy diffusion-weighted MRI for suspected prostate cancer: what does it reflect? Urologia internationalis. 2014; 93 (2): 170-175. ( PubMed, DOI )

  144. Miyajima Naoto, Tsutsumi Shinji, Sourbier Carole, Beebe Kristin, Mollapour Mehdi, Rivas Candy, Yoshida Soichiro, Trepel Jane B, Huang Ying, Tatokoro Manabu, Shinohara Nobuo, Nonomura Katsuya, Neckers Len. The HSP90 inhibitor ganetespib synergizes with the MET kinase inhibitor crizotinib in both crizotinib-sensitive and -resistant MET-driven tumor models. Cancer Research. 2013.12; 73 (23): 7022-7033. ( PubMed, DOI )

  145. Komai Yoshinobu, Numao Noboru, Yoshida Soichiro, Matsuoka Yoh, Nakanishi Yasukazu, Ishii Chikako, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. Journal of urology. 2013.09; 190 (3): 867-873. ( PubMed, DOI )

  146. Numao Noboru, Yoshida Soichiro, Komai Yoshinobu, Ishii Chikako, Kagawa Makoto, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer. Journal of urology. 2013.08; 190 (2): 502-508. ( PubMed, DOI )

  147. Yoshida Soichiro, Kobayashi Shuichiro, Koga Fumitaka, Ishioka Junichiro, Ishii Chikako, Tanaka Hiroshi, Nakanishi Yasukazu, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kihara Kazunori. Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report. European radiology. 2013.08; 23 (8): 2206-2214. ( PubMed, DOI )

  148. Fukushima Hiroshi, Masuda Hitoshi, Yokoyama Minato, Tatokoro Manabu, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Koga Fumitaka, Saito Kazutaka, Fujii Yasuhisa, Kihara Kazunori. Diabetes mellitus with obesity is a predictor of recurrence in patients with non-metastatic renal cell carcinoma. Japanese journal of clinical oncology. 2013.07; 43 (7): 740-746. ( PubMed, DOI )

  149. Yoshida Soichiro, Tsutsumi Shinji, Muhlebach Guillaume, Sourbier Carole, Lee Min-Jung, Lee Sunmin, Vartholomaiou Evangelia, Tatokoro Manabu, Beebe Kristin, Miyajima Naoto, Mohney Robert P, Chen Yang, Hasumi Hisashi, Xu Wanping, Fukushima Hiroshi, Nakamura Ken, Koga Fumitaka, Kihara Kazunori, Trepel Jane, Picard Didier, Neckers Leonard. Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis. Proceedings of the National Academy of Sciences of the United States of America. 2013.04; 110 (17): E1604-E1612. ( PubMed, DOI )

  150. Kijima Toshiki, Koga Fumitaka, Fujii Yasuhisa, Yoshida Soichiro, Tatokoro Manabu, Kihara Kazunori. Zoledronic acid sensitizes renal cell carcinoma cells to radiation by downregulating STAT1. PLoS One. 2013; 8 (5): e64615. ( PubMed, DOI )

  151. Tatokoro Manabu, Kihara Kazunori, Masuda Hitoshi, Ito Masaya, Yoshida Soichiro, Kijima Toshiki, Yokoyama Minato, Saito Kazutaka, Koga Fumitaka, Kawakami Satoru, Fujii Yasuhisa. Successful reduction of hospital-acquired methicillin-resistant Staphylococcus aureus in a urology ward: a 10-year study. BMC urology. 2013; 13 35. ( PubMed, DOI )

  152. Iwai Aki, Bourboulia Dimitra, Mollapour Mehdi, Jensen-Taubman Sandra, Lee Sunmin, Donnelly Alison C, Yoshida Soichiro, Miyajima Naoto, Tsutsumi Shinji, Smith Armine K, Sun David, Wu Xiaolin, Blagg Brian S, Trepel Jane B, Stetler-Stevenson William G, Neckers Len. Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells. Cell Cycle. 2012.10; 11 (19): 3649-3655. ( PubMed, DOI )

  153. Kijima Toshiki, Masuda Hitoshi, Yoshida Soichiro, Tatokoro Manabu, Yokoyama Minato, Numao Noboru, Saito Kazutaka, Koga Fumitaka, Fujii Yasuhisa, Kihara Kazunori. Antimicrobial prophylaxis is not necessary in clean category minimally invasive surgery for renal and adrenal tumors: a prospective study of 373 consecutive patients. Urology. 2012.09; 80 (3): 570-575. ( PubMed, DOI )

  154. Tatokoro Manabu, Koga Fumitaka, Yoshida Soichiro, Kawakami Satoru, Fujii Yasuhisa, Neckers Len, Kihara Kazunori. Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells. International journal of cancer. 2012.08; 131 (4): 987-996. ( PubMed, DOI )

  155. Yoshida Soichiro, Koga Fumitaka, Kobayashi Shuichiro, Ishii Chikako, Tanaka Hiroshi, Tanaka Hajime, Komai Yoshinobu, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. International journal of radiation oncology, biology, physics. 2012.05; 83 (1): e21-e27. ( PubMed, DOI )

  156. Koga Fumitaka, Kihara Kazunori, Yoshida Soichiro, Yokoyama Minato, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients. BJU international. 2012.03; 109 (6): 860-866. ( PubMed, DOI )

  157. Numao Noboru, Kawakami Satoru, Sakura Mizuaki, Yoshida Soichiro, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Yamamoto Shinya, Yonese Junji, Ishikawa Yuichi, Fukui Iwao, Kihara Kazunori. Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy. BJU international. 2012.03; 109 (5): 665-671. ( PubMed, DOI )

  158. Tsutsumi Shinji, Mollapour Mehdi, Prodromou Chrisostomos, Lee Chung-Tien, Panaretou Barry, Yoshida Soichiro, Mayer Matthias P, Neckers Leonard M. Charged linker sequence modulates eukaryotic heat shock protein 90 (Hsp90) chaperone activity. Proceedings of the National Academy of Sciences of the United States of America. 2012.02; 109 (8): 2937-2942. ( PubMed, DOI )

  159. Yoshida Soichiro, Koga Fumitaka, Tatokoro Manabu, Kawakami Satoru, Fujii Yasuhisa, Kumagai Jiro, Neckers Len, Kihara Kazunori. Low-dose Hsp90 inhibitors tumor-selectively sensitize bladder cancer cells to chemoradiotherapy. Cell Cycle. 2011.12; 10 (24): 4291-4299. ( PubMed, DOI )

  160. Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa, Ishii Chikako, Tanaka Hiroshi, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Kawakami Satoru, Kihara Kazunori. Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association. 2011.10; 18 (10): 727-730. ( PubMed, DOI )

  161. Kobayashi Shuichiro, Koga Fumitaka, Yoshida Soichiro, Masuda Hitoshi, Ishii Chikako, Tanaka Hiroshi, Komai Yoshinobu, Yokoyama Minato, Saito Kazutaka, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. European radiology. 2011.10; 21 (10): 2178-2186. ( PubMed, DOI )

  162. Yoshida Soichiro, Masuda Hitoshi, Ishii Chikako, Tanaka Hiroshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Usefulness of diffusion-weighted MRI in diagnosis of upper urinary tract cancer. AJR. American journal of roentgenology. 2011.01; 196 (1): 110-116. ( PubMed, DOI )

  163. Koga Fumitaka, Yoshida Soichiro, Tatokoro Manabu, Kawakami Satoru, Fujii Yasuhisa, Kumagai Jiro, Neckers Len, Kihara Kazunori. ErbB2 and NFkappaB overexpression as predictors of chemoradiation resistance and putative targets to overcome resistance in muscle-invasive bladder cancer. PLoS One. 2011; 6 (11): e27616. ( PubMed, DOI )

  164. Yoshida Soichiro, Koga Fumitaka, Kawakami Satoru, Ishii Chikako, Tanaka Hiroshi, Numao Noboru, Sakai Yasuyuki, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kihara Kazunori. Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology. 2010.02; 75 (2): 387-391. ( PubMed, DOI )

  165. Fukushima Hiroshi, Koga Fumitaka, Kawakami Satoru, Fujii Yasuhisa, Yoshida Soichiro, Ratovitski Edward, Trink Barry, Kihara Kazunori. Loss of DeltaNp63alpha promotes invasion of urothelial carcinomas via N-cadherin/Src homology and collagen/extracellular signal-regulated kinase pathway. Cancer Research. 2009.12; 69 (24): 9263-9270. ( PubMed, DOI )

  166. Koga Fumitaka, Kihara Kazunori, Fujii Yasuhisa, Yoshida Soichiro, Saito Kazutaka, Masuda Hitoshi, Kageyama Yukio, Kawakami Satoru. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study. BJU international. 2009.07; 104 (2): 189-194. ( PubMed, DOI )

  167. Yokoyama Minato, Fujii Yasuhisa, Yoshida Soichiro, Saito Kazutaka, Koga Fumitaka, Masuda Hitoshi, Kobayashi Tsuyoshi, Kawakami Satoru, Kihara Kazunori. Discarding antimicrobial prophylaxis for transurethral resection of bladder tumor: a feasibility study. Int J Urol. 2009.01; 16 (1): 61-63. ( PubMed, DOI )

  168. Koga Fumitaka, Yoshida Soichiro, Kawakami Satoru, Kageyama Yukio, Yokoyama Minato, Saito Kazutaka, Fujii Yasuhisa, Kobayashi Tsuyoshi, Kihara Kazunori. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. Urology. 2008.08; 72 (2): 384-388. ( PubMed, DOI )

  169. Yoshida Soichiro, Fujii Yasuhisa, Yokoyama Minato, Ishii Chikako, Saito Kazutaka, Koga Fumitaka, Masuda Hitoshi, Kobayashi Tsuyoshi, Kawakami Satoru, Kihara Kazunori. Female urethral diverticular abscess clearly depicted by diffusion-weighted magnetic resonance imaging. Int J Urol. 2008.05; 15 (5): 460-461. ( PubMed, DOI )

  170. Yoshida Soichiro, Saito Kazutaka, Koga Fumitaka, Yokoyama Minato, Kageyama Yukio, Masuda Hitoshi, Kobayashi Tsuyoshi, Kawakami Satoru, Kihara Kazunori. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy. BJU international. 2008.04; 101 (8): 978-981. ( PubMed, DOI )

  171. Masuda Hitoshi, Kihara Kazunori, Saito Kazutaka, Matsuoka Yoh, Yoshida Soichiro, Chancellor Michael B, de Groat William C, Yoshimura Naoki. Reactive oxygen species mediate detrusor overactivity via sensitization of afferent pathway in the bladder of anaesthetized rats. BJU international. 2008.03; 101 (6): 775-780. ( PubMed, DOI )

  172. Yoshida Soichiro, Masuda Hitoshi, Ishii Chikako, Saito Kazutaka, Kawakami Satoru, Kihara Kazunori. Initial experience of functional imaging of upper urinary tract neoplasm by diffusion-weighted magnetic resonance imaging. International journal of urology : official journal of the Japanese Urological Association. 2008.02; 15 (2): 140-143. ( PubMed, DOI )

  173. Yoshida Soichiro, Hayashi Tetsuo, Morozumi Makoto, Osada Hisato, Honda Norinari, Yamada Takumi. Three-dimensional assessment of urinary stone on non-contrast helical computed tomography as the predictor of stonestreet formation after extracorporeal shock wave lithotripsy for stones smaller than 20 mm. International journal of urology : official journal of the Japanese Urological Association. 2007.07; 14 (7): 665-667. ( PubMed, DOI )

  174. Yoshida Soichiro, Masuda Hitoshi, Yokoyama Minato, Kobayashi Tsuyoshi, Kawakami Satoru, Kihara Kazunori. Absence of prophylactic antibiotics in minimum incision endoscopic urological surgery (MEUS) of adrenal and renal tumors. International journal of urology : official journal of the Japanese Urological Association. 2007.05; 14 (5): 384-387. ( PubMed, DOI )

  175. Yoshida Soichiro, Hayashi Tetsuo, Okada Takemichi, Osada Hisato, Honda Norinari, Yamada Takumi. Discrimination between ureteral stent and stone by non-contrast helical computed tomography in the clinical setting. International journal of urology : official journal of the Japanese Urological Association. 2007.02; 14 (2): 171-173. ( PubMed, DOI )

  176. Yoshida Soichiro, Hayashi Tetsuo, Ikeda Jun, Yoshinaga Atsushi, Ohno Rena, Ishii Nobuyuki, Okada Takemichi, Osada Hisato, Honda Norinari, Yamada Takumi. Role of volume and attenuation value histogram of urinary stone on noncontrast helical computed tomography as predictor of fragility by extracorporeal shock wave lithotripsy. Urology. 2006.07; 68 (1): 33-37. ( PubMed, DOI )

  177. Hayashi Tetsuo, Yoshida Soichiro, Ohno Rena, Ishii Nobuyuki, Terao Toshiya, Yamada Takumi. Asthenospermia in hay fever patients improved by stopping treatment with histamine H1 receptor antagonists. Int J Urol. 2006.07; 13 (7): 1028-1030. ( PubMed, DOI )

  178. Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi, Futatsubashi Masami, Torizuka Tatsuo. C-choline positron emission tomography in bladder cancer: report of four cases. International journal of urology : official journal of the Japanese Urological Association. 2006.06; 13 (6): 829-831. ( PubMed, DOI )

  179. Hayashi Tetsuo, Yoshida Soichiro, Yoshinaga Atsushi, Ohno Rena, Ishii Nobuyuki, Yamada Takumi. HtrA2 is up-regulated in the rat testis after experimental cryptorchidism. International journal of urology : official journal of the Japanese Urological Association. 2006.02; 13 (2): 157-164. ( PubMed, DOI )

  180. Yoshida Soichiro, Hayashi Tetsuo, Ishii Nobuyuki, Yoshinaga Atsushi, Ohno Rena, Terao Toshiya, Watanabe Toru, Yamada Takumi, Osada Hisato. Bilateral renal angiomyolipoma coexistent with pulmonary lymphangioleiomyomatosis and tuberous sclerosis. International urology and nephrology. 2006; 38 (3-4): 413-415. ( PubMed, DOI )

  181. Hayashi Tetsuo, Yoshida Soichiro, Yoshinaga Atushi, Ohno Rena, Ishii Nobuyuki, Yamada Takumi. Improvement of oligoasthenozoospermia in epileptic patients on switching anti-epilepsy medication from sodium valproate to phenytoin. Scandinavian journal of urology and nephrology. 2005; 39 (5): 431-432. ( PubMed, DOI )

  182. Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi, Futatsubashi Masami, Torizuka Tatsuo. 11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging. Urologia internationalis. 2005; 74 (3): 214-220. ( PubMed, DOI )

  183. Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi, Ozawa Takachika. Cystic hamartoma of the renal pelvis. International journal of urology : official journal of the Japanese Urological Association. 2004.08; 11 (8): 653-655. ( PubMed, DOI )

  184. Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi, Kobayashi Satoshi. Malignant pheochromocytoma of the urinary bladder: effectiveness of radiotherapy in conjunction with chemotherapy. International journal of urology : official journal of the Japanese Urological Association. 2004.03; 11 (3): 175-177. ( PubMed )

  185. Yoshida Soichiro, Nakagomi Kazuaki, Goto Shuichi. Abscess formation in the prevesical space and bilateral thigh muscles secondary to osteomyelitis of the pubis--basis of the anatomy between the prevesical space and femoral sheath. Scandinavian journal of urology and nephrology. 2004; 38 (5): 440-441. ( PubMed, DOI )

▼display all

Books etc 【 display / non-display

  1. Kazunori Kihara, Yasuhisa Fujii, Kazutaka Saito, Fumitaka Koga, Noboru Numao, Yoh Matsuoka, Junichiro Ishioka, Minato Yokoyama, Hitoshi Masuda, Tatsuya Nagai, Soichiro Yoshida, Manabu Tatokoro, Toshiki Kijima, Naoko Kawamura, Masaharu Inoue, Masaya Ito. Gasless Single-Port RoboSurgeon Surgery in Urology. Springer, 2015.09 (ISBN : 978-4-431-54504-0)

  2. Yoshida S, Masuda H, Koga F, Tanaka H, Kihara K.. Functional Imaging in Oncology.. Springer, 2014 Chapter 46, Functional CT and MRI of the urinary system and adrenal glands.

Conference Activities & Talks 【 display / non-display

  1. 吉田 宗一郎 . Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive site-directed therapy. 第110回日本泌尿器科学会総会 2023.04.20

  2. Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using 8uorescence cystoscopy with orally administered 5-aminolevulinic acid. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

  3. Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

  4. Ishikawa Y, Sho U, Ishihara K, Hirose K, Soma T, Fujiwara M, Kobayashi M, Fan B, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. the 37th Annual European Association of Urology(EAU) Congress 2022.07

  5. Uehara S, Matsuoka Y, Yamamoto K, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Ohashi K, Fujii Y. MRI and MRI-targeted biopsy can detect cribriform cancer of the prostate. the 37th Annual European Association of Urology(EAU) Congress 2022.07

  6. Izumi H, Uehara S, Matsuoka Y, Yamamoto K, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Ohashi K, Fujii Y. Cribriform cancer is equally visible to non-cribriform cancer on multiparametric MRI: An analysis using texture features. the 37th Annual European Association of Urology(EAU) Congress 2022.07

  7. Ishikawa Y, Uehara S, Ishihara K, Hirose K, Soma T, Fujiwara M, Kobayashi M, Fan B, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using fluorescence cystoscopy with orally administered 5-aminolevulinic acid. the 37th Annual European Association of Urology(EAU) Congress 2022.07

  8. Fukuda S, Tanaka H, Tanabe K, Tamiya T, Kobayashi M, Yajima S, Nakamura Y, Fujiwara M, Ishikawa Y, Yamamoto T, Araki S, Yoshida S, Yokoyama M, Matsuoka Y, Otsuka Y, Koga F, Fujii Y. Local recurrence following partial nephrectomy in patients with renal cell carcinoma: a multicenter study. The 117th annual meeting of the American Urological Association 2022.05.13 New Orleans, USA

  9. Kobayashi M, Matsuoka Y, Uehara S, Tanaka Hiroshi, Nakamura Y, Uchida Y, Fukuda S, Tanaka Hajime, Yoshida S, Yokoyama M, Fujii Y. PIRADS score combined with positive core number on MRI-ultrasound fusion targeted prostate biopsy can predict the absence of pathological extraprostatic extension. AUA Annual Meeting 2022.05.13

  10. Uchida Y, Yokoyama M, Nakamura Y, Fukuda S, Uehara S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. ASSESSMENT OF ERECTILE AND EJACULATORY FUNCTIONS AFTER BLADDER-SPARING THERAPY AGAINST MUSCLE-INVASIVE BLADDER CANCER. the 22nd World Meeting of the International Society for Sexual Medicine 2022.05

  11. 福島啓司、木島敏樹、吉田宗一郎、横山みなと、石岡淳一郎、松岡陽、斎藤一隆、松原伸晃、湯浅健、増田均、米瀬淳二、影山幸雄、藤井靖久. 進行尿路上皮癌症例におけるペムブロリズマブの治療効果及び予後:化学放射線療法の治療歴との関連. 第108回 日本泌尿器科学会総会 2020.12.24

  12. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Who benefits from extra-target sampling in addition to intra-target sampling for the detection of adverse prostate pathology?: Stereological analysis of biopsy-proven cancer sites. The 35th Annual Congress of the European Association of Urology 2020.07.17 Amsterdam Netherlands.

  13. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Who needs extra-target sampling in addition to intra-target sampling for the detection of adverse prostate pathology?: Spatial analysis of biopsy-proven cancer sites. The 115th annual meeting of the American Urological Association 2020.05.15 Washington DC, USA

  14. Matsuoka Y, Ishioka J, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Saito K, Fujii Y. Apparent diffusion coefficient ratio as a quantitative imaging marker: Utility in a nomogram for predicting biochemical recurrence after radical prostatectomy. The 115th annual meeting of the American Urological Association 2020.05.15 Washington DC, USA

  15. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target sampling in addition to intra-target sampling for the detection of prostate cancer upgrading according to PIRADS scores. 12th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2020.02.09 Washington DC, USA

  16. Rie Kato, Hiroshi Fukushima, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Ishioka Junichiro, Yoh Matsuoka, Kazutaka Saito, Yukihiro Otsuka, Fumitaka Koga, Masataka Yano, Tetsuro Tsukamoto, Hitoshi Masuda, Tetsuo Okuno, Junji Yonese, Katsushi Nagahama, Shigeyoshi Kamata, Akira Noro, Yukio Kageyama, Toshihiko Tsujii, Shinji Morimoto, Yasuhisa Fujii.. The qSOFA score outperforms the SIRS score in predicting in-hospital mortality of obstructive pyelonephritis patients: results from a multi-institutional study.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  17. Rie Kato, Hiroshi Fukushima, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Ishioka Junichiro, Yoh Matsuoka, Kazutaka Saito, Yukihiro Otsuka, Fumitaka Koga, Masataka Yano, Tetsuro Tsukamoto, Hitoshi Masuda, Tetsuo Okuno, Junji Yonese, Katsushi Nagahama, Shigeyoshi Kamata, Akira Noro, Yukio Kageyama, Toshihiko Tsujii, Shinji Morimoto, Yasuhisa Fujii.. Predictive performance of the qSOFA score for in-hospital mortality of obstructive pyelonephritis patients: a multi-institutional study.. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam Netherlands.

  18. Ito T, Yoshida S, Taniguchi N, Sugimoto M, Moriyama S, Uehara S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. The utility of mixed reality model projection in ultrasound training for medical students.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  19. Yoshida S., Takahara T., Ishii C., Nakagawa K., Toda K., Arita Y., Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Yoshimura R., Fujii Y. Treatment outcomes of progressive site-directed therapy for oligoprogressive castration-resistant prostate cancer. . The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

  20. Yoshida S, Takahara T, Ishii C, Nakagawa K, Toda K, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Yoshimura R, Fujii Y. Treatment outcomes of progressive site-directed therapy for oligoprogressive castration-resistant prostate cancer. . 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  21. Yoshida S, Taniguchi N, Moriyama S, Uehara S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. . Application of virtual reality in patient education about MRI-ultrasound fusion prostate biopsy.. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

  22. Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores near targets are of value for the detection of significant cancer: Analysis of prostate biopsy mapping using multiplanar MRI reconstruction.. The 12th international symposium on focal therapy and imaging in prostate and kidney cancer, 2020 2020 Washington DC, USA

  23. Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores apart from targets are of limited value for the detection of significant cancer: Analysis of prostate biopsy mapping using multiplanar MRI reconstruction. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

  24. Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores away from targets are of limited value for the detection of significant cancer: Analysis of 3D prostate biopsy mapping using multiplanar MRI reconstruction.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  25. Toide M, Tanaka H, Uchida Y, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Stepwise diagnostic algorithm using CT and MRI for diagnosis of fat-poor angiomyolipoma in small renal masses: Prospective validation study. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

  26. Toide M, Tanaka H, Uchida Y, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Stepwise algorithm using CT and MRI for differential diagnosis of fat-poor angiomyolipoma in small renal masses: Prospective validation study. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  27. Matsumoto S, Yoshida S, Yamada I, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Tateishi U, Fujii Y. Utility of diffusion-weighted MRI radiomics features in differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma.. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam Netherlands.

  28. Tanaka H, Shimada W, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Campbell SC, Fujii Y. Novel classification model of tumour shape irregularity: significance for predicting potential oncologic risks in clinically localised renal cell carcinoma. The 35th Annual Congress of the European Association of Urology, 2020 (Virtual) 2020

  29. Moriyama S, Yokoyama M, Nakamura Y, Fukuda S, Fukushima H, Uehara S, Tanaka H, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Impact of nocturia on deteriorated renal function after adrenalectomy in patients with primary aldosteronism. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

  30. Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing’s syndrome. The 35th Annual European Association of Urology Congress Virtual, July 2020 2020

  31. Tanaka H, Shimada W, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Campbell SC, Fujii Y. Significance of tumor shape irregularity for predicting potential oncologic risks in clinically localized renal cell carcinoma. The 114th Annual Meeting of the American Urological Association, 2020 (Virtual) 2020

  32. Fukushima H, Kijima T, Uehara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Previous chemoradiotherapy may enhance the efficacy of pembrolizumab in advanced urothelial carcinoma patients. The 35th Annual Congress of the European Association of Urology 2020 Amsterdam, Netherlands

  33. Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Tanaka H, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Longitudinal change in urinary incontinence, lower urinary tract symptoms and quality of life after artificial urinary sphincter implantation. 114th annual meeting of the American Urological Association 2020 Washington DC, USA

  34. Maruyama R, Fukushima H, Fukuda S, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Low incidence of perioperative infections without antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: a prospective single-institutional study of 1339 patients. The 115th annual meeting of the American Urological Association 2020 Washington DC, USA

  35. Kato R, Fukushima H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Otsuka Y, Koga F, Yano M, Tsukamoto T, Masuda H, Okuno T, Yonese J, Nagahama K, Kamata S, Noro A, Kageyama Y, Tsujii T, Morimoto S, Fujii Y. The qSOFA score outperforms the SIRS score in predicting in-hospital mortality of obstructive pyelonephritis patients: results from a multi-institutional study. The 115th annual meeting of the American Urological Association 2020 Washington DC, USA

  36. Fukushima H, Fukuda S, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Abe Y, Takemura Y, Fujii Y. Relationship between nocturia and whole-body fluid distribution assessed by bioelectrical impedance. The 115th annual meeting of the American Urological Association 2020

  37. Kato R, Fukushima H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Otsuka Y, Koga F, Yano M, Tsukamoto T, Masuda H, Okuno T, Yonese J, Nagahama K, Kamata S, Noro A, Kageyama Y, Tsujii T, Morimoto S, Fujii Y. Predictive performance of the qSOFA score for in-hospital mortality of obstructive pyelonephritis patients: A multi-institutional study. The 35th Annual Congress of the European Association of Urology 2020 Amsterdam, Netherlands

  38. Matsuoka Y, Tanaka H,Kimura T, Moriyama S, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M,Ishioka J, Saito K, Fujii Y.. Usefulness of apparent diffusion coefficient ratio between tumor andnontumor as an imaging biomarker for prostate cancer.. The 114th annual meeting of the AmericanUrological Association, 2019.05.06 Chicago, USA

  39. Yoshida S., Tanaka H, Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Vesical Imaging-Reporting And Data System (VI-RADS) for bladder cancer staging with multiparametric MRI.. 113th annual meeting of the American Urological Association 2019.05.06 Chicago, USA.

  40. Yoshida S. AUA/JUA International Affiliate Society Meeting 2019 Theme 1: Bladder cancer, Tri-Modality treatment for MIBC.. 113th annual meeting of the American Urological Association 2019.05.05 Chicago, USA.

  41. Kijima T., Teramatsu R., Fukuda S., Fukushima H.,Moriyama S., Uehara S., Yasuda Y., Yoshida S., Yokoyama M., Ishioka J.Matsuoka Y., Saito K., Fujii Y. ,. High levels of heat-shock factor 1 (HSF1) are associated with poor prognosisin muscle-invasive bladder cancer patients treated with chemoradiation-basedbladder sparing protocol.. 113th annual meeting of the American Urological Association 2019.05.04 Chicago, USA

  42. Fukushima H., Toide M., Fukuda S., Moriyama S., Yasuda Y., Uehara S., Kijima T., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y.. Impact of bladder neck involvement and positive urine cytology in substratifying intermediate-risk non-muscle-invasive bladder cancer patients based on the prediction of high-risk recurrence. . 113th annual meeting of the American Urological Association 2019.05.04 Chicago, USA

  43. Matsuoka Y, Uehara S, Yoshida S, Tanabe K, Tanaka H, Kimura T, Moriyama S,Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y.. Who benefits additionally from concurrent systematic biopsy at the time ofMRI-ultrasound fusion targeted biopsy to detect significant prostate cancer?. The 114th annual meeting of the American Urological Association 2019.05.04 Chicago,USA

  44. Yoshida S., Fukuda S., Moriyama S., Yokoyama M., Taniguchi N., Shinjo K., Sugimoto M., Saito K., Fujii Y.. Holographic surgical planning of partial nephrectomy using a wearable mixed reality computer. . 113th annual meeting of the American Urological Association 2019.05.04 Chicago, USA.

  45. 木島敏樹, 森山真吾, 福田翔平, 上原翔, 安田庸輔, 吉田宗一郎横山みなと, 石岡準一郎, 松岡陽, 齋藤一隆, 木原和徳, 藤井靖久.,. 副腎皮質癌の治療成績:再発例に対する集学的治療(化学療法、放射線療法、再発巣切除)の有効性. . 第107回日本泌尿器科学会総会 2019.04.18 名古屋

  46. Kijima T., Teramatsu R., Fukuda S., Fukushima H.,Moriyama S., Uehara S., Yasuda Y., Yoshida S., Yokoyama M., Ishioka J.,Matsuoka Y., Saito K., Fujii Y.. High levels of heat-shock factor 1 (HSF1) are associated with poor prognosis in muscle-invasive bladder cancer patients treated with chemoradiation-based bladder sparing protocol. . The 34th Annual Congress of the EuropeanAssociation of Urology 2019.03.18 Barcelona, Spain

  47. Fukushima H., Saito K., Yasuda Y., Uehara S., Kijima T., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Kihara K., Koga F., Okuno T., Arisawa C., Kamata S., Nagahama K., Masuda H., Yonese J., Kageyama Y., Noro A., Tsujii T., Morimoto S., Fujii Y. . Obesity-specific effect of sex on prognosis of upper urinary tract urothelial carcinoma patients undergoing radical nephroureterectomy: A Japanese multicenter study. . The 34th Annual Congress of the European Association of Urology 2019.03.18 Barcelona, Spain

  48. Fukushima H., Kijima T., Toide M., Fukuda S., Moriyama S., Yasuda Y., Uehara S., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Tetra-modality bladder sparing therapy can be a viable treatment option for muscle-invasive bladder cancer patients with sarcopenia. . The 34th Annual Congress of the European Association of Urology 2019.03.18 Barcelona, Spain

  49. Yoshida S., Takahara T., Ishii C., Nakagawa K., Toda K., Arita Y., Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Yoshimura R., Fujii Y.. Loco-regional radiotherapy targeting oligo-progressive lesions in castration-resistant prostate cancer patients: Intra-pelvic localized progressive lesions are the good targets. . The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain

  50. Kijima T., Fukuda S., Fukushima H., Moriyama S., Uehara S., Yasuda Y.,Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y.. Clinical outcomes of muscle-invasive bladder cancer patients withhydronephrosis treated with tetramodality bladder sparing therapyincorporating consolidative partial cystectomy. . The34th Annual Congress of the European Association of Urology, 2019.03.17 Barcelona, Spain

  51. Fukushima H., Toide M., Fukuda S., Moriyama S., Yasuda Y., Uehara S., Kijima T., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y.. Substratification of intermediate-risk non-muscle-invasive bladder cancer based on the prediction of high-risk recurrence: Impact of bladder neck involvement and positive urine cytology. . The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain

  52. Kasumi Kaneko, Soichiro Yoshida, Yuki Arita, Kouhei Yamamoto, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted MRI. The 34th Annual Congress of the European Association of Urology, 2019.03.17 Barcelona, Spain.

  53. Yoshida S., Fukuda S., Moriyama S., Yokoyama M., Taniguchi N., Shinjo K., Sugimoto M., Saito K., Fujii Y. . Holographic surgical planning of partial nephrectomy using a wearable mixed reality computer. . The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain

  54. Yoshida S., Tanaka H, Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Vesical Imaging-Reporting And Data System (VI-RADS) for bladder cancer staging with multiparametric MRI.. The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain.

  55. Uchida Y., Yoshida S., ShimodaH., TanakaH., SakamotoT., UeharaS., YasudaY.,KijimaT., YokoyamaM., IshiokaJ., MatsuokaY., SaitoK., Fujii Y.. Differentiation of chromophobe renal cell carcinoma and renal oncocytomawith whole-lesion ADC analysis on diffusion-weighted MRI. The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain.

  56. Matsuoka Y, Uehara S, Yoshida S, tanabe K, Tanaka H, KimuraT, Moriyama S, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y.. Who gains additional benefits from systematic biopsy concurrently performedwith MRI-ultrasound fusion targeted biopsy in the detection of significantprostate cancer?. he 34th Annual Congress of the European Association of Urology, 2019.03.16 Barcelona, Spain

  57. Kijima T., Fukuda S., Fukushima H., Moriyama S., Uehara S., Yasuda Y.. Clinical outcomes of muscle-invasive bladder cancer patients with. Genitourinary Cancers Symposium 2019.02.15 San Francisco, USA

  58. 木島敏樹、安田庸輔、上原翔、吉田宗一郎、横山みなと、石岡淳一郎、松岡陽、齋藤一隆、木原和徳、藤井靖久. 筋層浸潤膀胱癌に対する4者併用膀胱温存療法(TUR+低用量化学放射線療法+膀胱部分切除):Histologic variantを有する症例での検討.. 日本泌尿器腫瘍研究会第4回学術集会 2018.10.20 横浜

  59. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, KijimaT, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. The role of MRI-targeted biopsy in prediction of adverse pathologicaland oncological outcome after radical prostatectomy. The 114th annual meeting of the American Urological Association 2018.05.20 San Francisco

  60. Yokoyama M, Kawamura N, Uehara S, Yasuda Y, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy.. The 113rd annual meeting of the American Urological Association 2018.05.19 San Francisco, USA

  61. 1 Yasuda Y, Saito K, Soma T, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kihara K, Fujii Y. The outcome of gasless laparoscopic single-port clampless sutureless partial nephrectomy using three-dimensional head-mounted display. he outcome of gasless laparoscopic single-port clampless sutureless partial nephrectomy using three-dimensional head-mounted display. The 112th annual meeting of the American Urological Association 2018.05.18 San Francisco, USA

  62. Matsuoka Y, Ishioka J, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Saito K, Kihara K, Fujii Y. MRI-based risk assessment for postoperative biochemical recurrenceusing the Prostate Imaging Reporting and Data System (PI-RADS) scoresand capsular contact length. The 114th annual meeting of the American Urological Association 2018.05.18 San Francisco

  63. Junichiro Ishioka*, Yoh Matsuoka, Sho Uehara, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Kazutaka Saito, Tomo Kimura, Kosei Kudo,Itsuo Kumazawa, Yasuhisa Fujii. Deep learning with a convolutional neural network algorithm for fully automated detection of prostate cancer using pre-biopsy MRI. 112th annual meeting of the American Urological Association 2018.05.18 San Francisco, USA

  64. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, KijimaT, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. Clinical significance of MRI-targeted biopsy for the risk stratification of oncological outcome after radical prostatectomy. 第106回日本泌尿器科学会総会 2018.04.19 京都

  65. 木島 敏樹, 吉田 宗一郎, 横山みなと, 石岡 淳一郎, 松岡 陽, 齋藤 一隆, 木原 和徳, 藤井 靖久.. 熱ショック因子(Heat shock factor 1: HSF1)阻害によるARスプライスバリアントを標的とした去勢抵抗性前立腺癌に対する新規治療.. 第106回日本泌尿器科学会総会 2018.04.19 京都

  66. 吉田 宗一郎. 全身拡散強調画像の歴史と発展. 第77回日本医学放射線学会総会、シンポジウム12 2018.04.15 横浜

  67. Waseda Y, Yoshida S, Takahara T, Arita Y, Sakamoto T, Yajima S, Uehara S, Yasuda Y, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Feasibility of perfusion MRI to predict renal function after nephroureterectomy in upper tract urothelial carcinoma patients. The 33th European Association of Urology annual congress 2018.03.26 Copenhagen, Denmark

  68. Yajima S, Yoshida S, Takahara T,Arita Y, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Absence of inchworm sign on DWI as a predictive marker for progression in pT1 bladder cancer. The 18th annual meeting of the European Association of Urology 2018.03.19 Copenhagen, Denmark

  69. Yoshida S., Takahara T., Ishii C., Arita Y., Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y. 935 METastasis Reporting And Data System for Prostate cancer (MET-RADS-P) score of whole-body DWI as a prognostic biomarker for castration-resistant prostate cancer. The 33th Annual Congress of the European Association of Urology 2018.03.19 Copenhagen, Denmark

  70. Kaneko K, Yoshida S, Takahara T, Sakamoto T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . Diffusion-weighted MRI as an imaging biomarker for histological grade of bladder cancer: Semi-automatic segmentation analysis. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  71. Soma T, Yoshida S, Tanaka H, Uehara S, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . The usefulness of diffusion-weighted MRI in the differential diagnosis of urachal disorders. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  72. Waseda Y, Yoshida S, Takahara T, Arita Y, Sakamoto T, Yajima S, Uehara S, Yasuda Y, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Feasibility of perfusion MRI to predict renal function after nephroureterectomy in upper tract urothelial carcinoma patients.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  73. Uehara S, Yoshida S, Matsuoka Y, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. . Head-mounted display assisted magnetic resonance/ultrasound fusion prostate biopsy system.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  74. Uehara S, Yoshida S, Tanaka H, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . Prediction of intraoperative urinary collecting system entry in patients with peripheral renal tumors undergoing partial nephrectomy: Usefulness of tumor-centered multiplanar reconstruction.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  75. Uehara S, Matsuoka Y, Tanaka H, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Do the Prostate Imaging Reporting and Data System scores reflect oncological outcome? Potential usefulness of scoring criteria-based assessment. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  76. Yoshida S, Takahara T, Ishii C, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . METastasis reporting and data system for prostate cancer score of whole-body DWI as a prognostic biomarker for castration-resistant prostate cancer. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  77. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Clinical significance of MRI-targeted biopsy in prediction of adverse pathological and oncological outcome after radical prostatectomy.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  78. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Clinical significance of MRI-targeted biopsy in prediction of adverse pathological and oncological outcome after radical prostatectomy.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  79. Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Characteristics of global Gleason grading for MRI-targeted biopsy in comparison with systematic biopsy and prostatectomy grades.. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  80. Kaneko K, Yoshida S, Takahara T, Sakamoto T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Diffusion-weighted MRI as an imaging biomarker for histological grade of bladder cancer: Semi-automatic segmentation analysis. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.19 Copenhagen, Denmark

  81. Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Favorable locoregional control in patients with histologic variants of urothelial carcinoma treated with tetra-modality bladder-sparing protocol incorporating consolidative partial cystectomy with lymph node dissection. . 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.18 Denmark

  82. Soma T, Ihioka J, Tanaka H, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y. Computer-aided differential diagnosis of fat-poor angiomyolipoma using a deep neural networks algorithm in enhanced CT and T2-weighted magnetic resonance imaging. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.17 Denmark

  83. Ishioka J, Matsuoka Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Kimura T, Kudo K, Kumazawa I, Fujii Y. Computer-aided diagnosis with a convolutional neural network algorithm for fully automated detection of prostate cancer using pre-biopsy MRI. 欧州泌尿器科学会(The 33th European Association of Urology annual congress, Copenhagen, Denmark) 2018.03.16 Denmark

  84. Yuma Waseda, Kazutaka Saito, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazunori Kihara, Yasuhisa Fujii. Predictive ability of renal cortex enhancement in dynamic CT for residual renal function after nephroureterectomy: Comparative study with renography.. AUA Annual Meeting 2017 2017.05.15 Boston

  85. Takayuki Nakayama, Toshiki Kijima, Soichiro Yoshida, Fumitaka Koga, Kazunori Kihara and Yasuhisa Fujii. Zoledronic acid sensitizes castration-resistant prostate cancer cells to radiotherapy and chemotherapy by downregulating STAT1. AUA Annual Meeting 2017 2017.05.15

  86. Inoue M, Fujii Y, Ito M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K.. Incidence and risk factors of postoperative hypertension after partial nephrectomy for renal tumors. AUA Annual Meeting 2017 2017.05.14 Boston

  87. Yuma Waseda, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. New predictive scoring model for recurrence incorporating bladder neck involvement in patients with non-muscle-invasive bladder cancer.. AUA Annual Meeting 2017 2017.05.13 Boston

  88. 井上雅晴,井靖久,藤将也,木島敏樹,田宗一郎,横山みなと,石岡淳一郎,松岡 陽,齋藤一隆,木原和徳. 腎部分切除後の高血圧発症・増悪およびそのリスク因子. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

  89. 田中一,吉田宗一郎,井上雅晴,伊藤将也,木島敏樹,横山みなと,石岡淳一郎,松岡陽,齋藤一隆,木原和徳,藤井靖久. 膀胱癌の免疫組織化学染色に基づく分子サブタイプ分類と化学放射線療法感受性及び予後の解析:筋層浸潤膀胱癌に対する新たな治療戦略に向けて. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

  90. 川村尚子,横山みなと,中山貴之,田中一,井上雅晴,伊藤将也,木島敏樹,吉田宗一郎,石岡淳一郎,松岡陽,齋藤一隆,木原和徳,藤井靖久. 無阻血腎部分切除後の急性腎障害:発生率と術後腎機能への影響. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島、日本

  91. 吉田宗一郎、高原太郎、石井千佳子、田中一、井上雅晴、伊藤将也、木島敏樹、横山みなと、石岡淳一郎、松岡陽、齋藤一隆、木原和徳、藤井靖久. DWIBS法による全身拡散強調MRIを用いた去勢抵抗性前立腺癌の予後評価. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

  92. Matsuoka Y, Tanaka H, Kimura T, Ito M, Inoue M, Kijima T, Yoshida S,. MRI-targeted biopsy vs. systematic biopsy in prediction of biochemical recurrence after radical prostatectomy. 第105回日本泌尿器科学会総会 2017.04.21 Kagoshima

  93. Nakamura Yuki, Tanaka Hajime, Fujii Yasuhisa, Inoue Masaharu, Ito Masaya, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: A comparison of oncological outcomes between primary and progressive diseases. . 32nd Annual EAU Congress 2017.03.27 London, UK

  94. Matsuoka Y, Ishioka J, Tanaka H, Kimura T, Inoue M, Ito M, Kijima T, Yoshida. Characteristics of MRI staging using PI-RADS version 2 and its predictive performance for biochemical recurrence after radical prostatectomy compared to PI-RADS version 1. 32nd Annual EAU Congress 2017.03.27 London

  95. N. Kawamura, K. Saito, M. Inoue, M. Ito, T. Kijima, S. Yoshida,M. Yokoyama, J. Ishioka, Y. Matsuoka, K. Kihara, Y. Fujii. Adherent perinephric fat in Asian patients: predictors, andimpact on perioperative outcomes of partial nephrectomy. 32nd Annual EAU Congress 2017.03.27 London、England

  96. N. Kawamura, M. Yokoyama, T. Nakayama, H. Tanaka, M. Inoue, M.Ito, T. Kijima, S. Yoshida, J. Ishioka, Y. Matsuoka, K. Saito, K. Kihara,Fujii Y.. Acute kidney injury after clampless partial nephrectomy:incidence, predictors, and its low impact on intermediate-term renalfunction . 32nd Annual EAU Congress 2017.03.27 London、England

  97. Saito K, Matsuoka Y, Numao N, Hayashi K, Toda K, Ito M, Inoue M, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Yoshimura R, Kihara K. Hemi-gland brachytherapy for localized prostate cancer. 9th International Symposium on Focal Therapy and Imaging in prostate & kidney cancer 2016.06.23 Durham, USA

  98. Matsuoka Y, Saito K, Numao N, Tanaka H, Inoue M, Ito M, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Kihara K. Risk assessment for undertreatment in focal therapy and its applicability to intermediate- and high-risk prostate cancer. 9th International Symposium on Focal Therapy and Imaging in prostate & kidney cancer 2016.06.23 Durham, USA

  99. S. Yoshida, F. Koga, H. Tanaka, H. Fukushima, Y. Nakanishi, M. Yokoyama, J. Ishioka, Y. Matsuoka, N. Numao, K. Saito, Y. Fujii, K. Kihara.. Apparent diffusion coefficient ratio as a potential inter-institutional marker for histological grade of bladder cancer. 24th International Society of Magnetic Resonance in Medicine (ISMRM) 2016.05.12 Singapore

  100. Matsuoka Y et al. Impact of the Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) on the assessment of extracapsular extension in prostate cancer: A multireader study.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.09 USA

  101. 13.Nakayama T, Kazutaka S, Fujii Y, Waseda Y, Moriyama S, Tanaka H, Kawamura N, Inoue M, Ito M, Yoshida, S, Yokoyama M, Matsuoka Y, Numao N, Kihara K. Association of M2 macrophage invasion with C-reactive protein in renal cell carcinoma.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.09 San diego, USA

  102. Moriyama S et al. MRI intensity ratio curve analysis: a new objective method for characterizing small renal masses.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.09 San diego, USA

  103. Masaharu Inoue, Fumitaka Koga, Soichiro Yoshida, Hajime Tanaka, Shuichiro Kobayashi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Predictive model for therapeutic resistance using ERBB2 expression status and Ki-67 labeling index in muscle-invasive bladder cancer patients treated with chemoradiotherapy-based bladder-sparing protocol. AUA2016 Annual Meeting 2016.05.09 San Diego, USA

  104. Matsuoka Y et al. Impact of prebiopsy magnetic resonance imaging (MRI) on preoperative risk stratification for biochemical recurrence after radical prostatectomy. . 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.08 USA

  105. Fujii Y et al.. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Comparison of oncological and functional outcomes between older and younger patients. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.08 USA

  106. Ishioka J et al. Prognostic impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma. A multicenter study. . 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.08 San diego, USA

  107. Yoshida S et al. . Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.07 San diego, USA

  108. Ito M et al. Likelihood of underlying Lynch syndrome in Japanese upper tract urothelial carcinoma patients. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.07 San diego, USA,

  109. Fujiwara M et al.. Feasibility of non-use of antimicrobial prophylaxis in minimally invasive. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.07 San diego, USA

  110. Kobayashi M et al. Maximum standardized uptake value of 18F-FDG PET/CT predicts survival of patients with advanced urothelial carcinoma. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.07 San diego, USA

  111. Tanaka H et al. Development and validation of a novel stepwise algorithm using CT and MRI for diagnosis of fat-poor angiomyolipoma in small renal masses. . 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.07

  112. Ishioka J et al.. The incidence of late bladder tumor recurrence of upper tract urothelial carcinoma and optimal cystoscopic follow-up: A multicenter study.. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.06 San diego, USA

  113. Matsuoka Y et al. Applicability analysis of focal therapy to intermediate- and high-risk prostate cancer. . 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.06 USA

  114. Numao N et al. Optimal combination of MRI-targeted biopsy and systematic biopsy for men with suspicion of prostate cancer. . 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.06 San diego, USA

  115. Waseda Y et al. Impact of elevated urinary metanephrine/normetanephrine and impaired glucose tolerance test on the development of hypoglycemia following removal of pheochromocytoma. 米国泌尿器科学会(annual meeting of the American Urological Association) 2016.05.06 San diego

  116. Nakamura Y et al. . High specificity of diffusion-weighted MRI in differentiating residual bladder cancer from postoperative changes. 米国泌尿器科学会(annual meeting of the American Urological Association 2016.05.06 San diego, USA

  117. Nakamura Y et al.. Masked renal dysfunction in patients with adrenal Cushing's syndrome manifested by adrenalectomy. 米国泌尿器科学会(annual meeting of the American Urological Association 2016.05.06 San diego, USA

  118. Masaharu Inoue, Fumitaka Koga, Soiciro Yoshida, Hajime Tanaka, Shuichiro Kobayashi, Masaya Ito, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labeling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. the 31st Annual EAU Congress 2016.03.14

  119. Yoshida S et al. The utility of diffusion-weighted MRI as an imaging biomarker of upper urinary tract cancer: A preoperative prognostic indicator reflecting histological grade. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Munich, Germany

  120. Inoue M et al. . Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labelling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Munich, Germany

  121. 4.Kawamura N, Yokoyama M, Fujii Y, Inoue M, Ito M, Yoshida S, Ishioka J, Numao N, Matsuoka Y, Saito K, Kihara K.. Longitudinal preservation of renal function after clamp-less partial nephrectomy: An analysis of patients with chronic kidney disease.. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Germany

  122. Matsuoka Y et al. Impact of PI-RADS version 2 on MRI diagnosis for extracapsular extension of prostate cancer: A multireader study. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.14 Germany

  123. 1.Fujii Y, Kihara K, Tanaka H, Saito K., Yoshida S, Yokoyama M., Ishioka J, Matsuoka Y, Numao N. . Bladder-sparing protocol consisting of ow-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Oncological and functional outcome in elderly patients.. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13 Germany

  124. Nakamura Y et al. Renal dysfunction manifestation in patients with adrenal Cushing's syndrome after adrenalectomy. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13 Munich, Germany

  125. Waseda Y. et al.. Elevation of urinary metanephrine/normetanephrine and impairment of glucose tolerance predict the development of hypoglycemia after resection of pheochromocytoma. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13

  126. Moriyama S et al. A new quantitative method for characterizing small renal masses: MRI intensity ratio curve analysis. 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.13 Munich, Germany

  127. Ishioka J et al. When should patients undergo prostate biopsy? Decision analysis using differences in the health-related quality-of-life between pre-biopsy healthy men and patients with castration-resistant prostate cancer. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.12 Munich, Germany

  128. Fujiwara M et al.. Antibiotic prophylaxis is avoidable in minimally invasive clean surgery for renal or adrenal tumors: A prospective study of 678 cases. Munich, Germany 2016.03.12 Munich, Germany

  129. Tanaka H et al. Novel stepwise algorithm using CT and MRI for differential diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. . 欧州泌尿器科学会(European Association of Urology annual congress) 2016.03.12 Munich, Germany

  130. Matsuoka Y, Numao N, Saito K, Tanaka H, Ito M, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Kihara K. Eligibility analysis for focal therapy based on prostatectomy findings: Does intermediate-risk cancer have a higher likelihood of undertreatment than low-risk cancer?. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam, Netherland

  131. Numao N, Ito M, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y, Kihara K. Efficient sampling methods in systematic biopsy that could be performed in combination with MRI-guided biopsy. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam, Netherland

  132. Saito K, Matsuoka Y, Numao N, Hayashi K, Yoshida S, Yokoyama M, Ishioka J, Fujii Y, Yoshimura R, Kihara K. Focal therapy for prostate cancer with hemi-gland low dose rate brachytherapy. 8th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer 2015.06.21 Amsterdam

  133. Fujii Y., Kihara K., Tanaka H., Tatokoro M., Yoshida S.m Yokoyama M., Ishioka J., Matusoka Y., Numao N., Saito K. Oncological and functional outcomes in muscle-invasive bladder cancer patients undergoing bladder-sparing treatment consisting of low-dose chemoradiotherapy and consolidative partial cystectomy. The 111th annual meeting of the American Urological Association 2015.05.18 New Orleans, USA

  134. Yoshida S., Tanabe K., Koga F., Inoue M., Kobayashi S., Ishioka J., Tamura T., Sugawara E., Saito K., Akashi T., Fujii Y., Kihara K. Favorable survival outcomes after a chemoradiation-based multimodal approach against muscle-invasive bladder cancer with high Ki-67 expression. The 111th annual meeting of the American Urological Association 2015.05.18 New Orleans, USA

  135. Numao N., Ito M., Uchida Y., Yoshida S., Nakayama T., Inoue M., Tatokoro M., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y., Kihara K. Optimal MRI-targeted biopsy sampling number. The 111th annual meeting of the American Urological Association 2015.05.17

  136. Yoshida S., Fukuyo T., Ito M., Tatokoro M., Ishioka J., Matsuoka Y., Numao N., Saito K., Fujii Y., Kihara K. Development of new three-dimensional image system for transurethral surgery. The 111th annual meeting of the American Urological Association 2015.05.16 New Orleans, USA

  137. Yoshida S., Fukuda S., Kanda T., Fukui N., Saito K., Fujii Y., Kageyama Y, Kihara K. Novel image monitoring system using a head-mounted display for assistants in da Vinci surgery. The 111th annual meeting of the American Urological Association 2015.05.16 New Orleans, USA,

  138. 7.Moriyama S., Saito K., Ishioka J., Kageyama Y., Morimoto S., Arisawa C., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Matsuoka Y., Numao N., Fujii Y., Kihara K. Preoperative selection algorithm for eligible neoadjuvant chemotherapy patients in upper tract urothelial carcinomas. The 111th annual meeting of the American Urological Association 2015.05.15 New Orleans, USA

  139. Tanaka H., Fujii Y., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N., Saito K., Yonese J., Kihara K. Development and validation of a novel prediction model for fat-poor angiomyolipoma in small renal masses based on radiological and clinical features. The 111th annual meeting of the American Urological Association 2015.05.15 New Orleans, USA

  140. 2.Ishioka J, Yokoyama M, Waseda Y,Kawamura N, Itoh M, Tatokoro M, Yoshida S, Matsuoka Y,Numao N, Saito K, Arisawa C, Morimoto S, Kageyama Y,Fujii Y, Kihara K. Preoperative prediction of postoperative renal function for upper tract urothelial carcinoma patients: Concerning issues of perioperative renal impairment and the use of cisplatin-based chemotherapy. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

  141. Yoshida S., Fukuyo T., Ito M., Tatokoro M., Yokoyama M, Ishioka J., Matsuoka Y., Numao N., Saito K., Fujii Y., Kihara K. A novel three-dimensional image display system for transurethral surgery. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

  142. 8.Nakamura Y. , Numao N. , Yoshida S. , Komai Y. , Ito M. , Tatokoro M. , Yokoyama M. , Ishioka J. , Matsuoka Y. , Saito K. , Fujii Y. , Kihara K.. Transrectal 12-core prostate biopsy and MRI have a comparable risk of missing significant prostate cancer in men with PSA less than 10ng/ml and normal DRE. The 30th Annual Congress of the European Association of Urology 2015.03.23 Madrid, Spain

  143. 5.Tanaka H, Fujii Y, Ito M, Tatokoro M, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Yonese J, Kihara K. Novel prediction model for fat-poor angiomyolipoma in small renal masses based on radiological and clinical features. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

  144. 14.Fujii, Y., Kihara, K., Numao, N., Tanaka H., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N., Saito K. Selective bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: oncological and functional outcome. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

  145. 7.Moriyama S., Saito K., Ishioka J., Kageyama Y., Morimoto S., Arisawa C., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Matsuoka Y., Numao N., Fujii Y., Kihara K. Preoperative prediction algorithm for the selection of candidates for neoadjuvant chemotherapy in upper tract urothelial carcinomas. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

  146. 9.Nakayama T., Saito K., Fujii Y., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N, Kihara K. Prognostic comparison of serum biomarkers for cancer-specific survival of renal cell carcinoma undergoing nephrectomy: C-reactive protein has the highest predictive ability on survival. The 30th Annual Congress of the European Association of Urology 2015.03.21

  147. 10.Numao N., Ito M., Uchida Y., Yoshida S., Nakayama T., Inoue M., Tatokoro M., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Fujii Y., Kihara K. Optimal number of sampling cores in MRI-targeted biopsy, Madrid. The 30th Annual Congress of the European Association of Urology 2015.03.21 Madrid, Spain

  148. Masaharu Inoue, Yasuhisa Fujii, Minato Yokoyama, Masaya Ito, Manabu Tatokoro, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Kazunori Kihara. Progression of hypertension after partial nephrectomy in Japanese patients with renal tumors. 30th Annual EAU Congress 2015.03.21 Madrid, Spain

  149. Yoshida Soichiro, Koga Fumitaka, Tanaka Hiroshi, Satoh Shiro, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kasutaka, Fujii Yasuhisa, Kihara Kazunori. Diffusion-weighted MRI for assessing the response of muscle-invasive bladder cancer to chemoradiotherapy. (Yoshida Soichiro, Koga Fumitaka, Tanaka Hiroshi, Satoh Shiro, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kasutaka, Fujii Yasuhisa, Kihara Kazunori). The 108th annual meeting of the American Urological Association 2014.05.17 Orlando, USA

  150. Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Inoue Masaharu, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa. Head-mounted display-based personal integrated-image monitoring system for TURP. (Yoshida Soichiro, Kihara Kazunori, Takeshita Hideki, Inoue Masaharu, Nakanishi Yasukazu, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Numao Noboru, Saito Kazutaka, Fujii Yasuhisa). The 29th Annual Congress of the European Association of Urology 2014.04.13 Stockholm, Sweden

  151. Yoshida S, Kobayashi S, Koga F, Ishioka J, Ishii C, Tanaka H, Nakanishi Y, Matsuoka Y, Numao N, Saito K, Masuda H, Fujii Y, Kihara K.. The ADC value is a prognostic biomarker of upper urinary tract cancer: Potential application to preoperative risk stratification.. The 28th Annual Congress of the European Association of Urology 2013.03.16

▼display all

Awards & Honors 【 display / non-display

  • Best Poster Presentation, The 33rd Annual Congress of the European Association of Urology,European Association of Urology,2018.03

  • Best Poster Presentation, 110th annual meeting of the American Urological Association,American Urological Association ,2016.05

  • Best Poster Presentation: The 30th Annual Congress of the European Association of Urology,European Association of Urology,2016.03

  • Best Poster Presentation, The 31th Annual Congress of the European Association of Urology,European Association of Urology,2016.03

  • Outstanding Poster Presentation,American Urological Association,2014.05

  • Prize for the Third Best Abstract (Oncology),European Association of Urology,2010.04

  • Best poster presentation award,European Association of Urology,2010.04

▼display all